Versatility of liquid crystalline nanoparticles in inflammatory lung diseases

Chan Y 1 , Mehta M 2 , Paudel KR 3 , Madheswaran T 4 , Panneerselvam J 4 , Gupta G 5 Show all authors , Su QP 6 , Hansbro PM 3 , MacLoughlin R 7 , Dua K 2 , Chellappan DK 8

Affiliations 

  • 1 School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia
  • 2 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, 2007, Australia
  • 3 Centre for Inflammation, Centenary Institute, Sydney, NSW, 2050, Australia
  • 4 Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia
  • 5 School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India
  • 6 School of Biomedical Engineering, Faculty of Engineering & Information Technology, University of Technology Sydney, Sydney, NSW, 2007, Australia
  • 7 Aerogen, IDA Business Park, Dangan, Galway, H91 HE94, Ireland
  • 8 Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia
Nanomedicine (Lond), 2021 08;16(18):1545-1548.
PMID: 34184917 DOI: 10.2217/nnm-2021-0114

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications